Frontline ibrutinib saves money over chemoimmunotherapyNovember 20, 2019CLLBusiness of MedicineB Cell Lymphoma
Consider renal function in TLS risk assessment of venetoclax-treated CLLOctober 29, 2019CLLB Cell Lymphoma
PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitorsOctober 16, 2019CLLB Cell Lymphoma
Targeted agents vs. chemoimmunotherapy as first-line treatment of CLLOctober 3, 2019CLLB Cell Lymphoma
German CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019CLLB Cell Lymphoma
GALACTIC CLL trial: Obinutuzumab consolidation helps eradicate MRDSeptember 26, 2019CLLB Cell Lymphoma
